USANA Health Sciences Files 10-Q for Q1 2024
Ticker: USNA · Form: 10-Q · Filed: 2024-05-07T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
USANA 10-Q filed. Q1 2024 financials out.
AI Summary
USANA Health Sciences Inc. filed its 10-Q for the period ending March 30, 2024. The company, incorporated in Utah, operates in the medicinal chemicals and botanical products sector. Key financial data and reporting details are included in this filing.
Why It Matters
This filing provides investors with a quarterly update on USANA's financial performance and operational status, crucial for understanding the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- 20240330 — Period End Date (The filing covers financial data up to this date.)
- 20240507 — Filing Date (The date the report was officially submitted to the SEC.)
Key Players & Entities
- USANA HEALTH SCIENCES INC (company) — Filer
- 20240330 (date) — Period of Report
- 20240507 (date) — Filing Date
- SALT LAKE CITY (location) — Business Address City
- UT (location) — Business Address State
FAQ
What is the primary business of USANA Health Sciences Inc.?
USANA Health Sciences Inc. is classified under the Standard Industrial Classification code 2833 for Medicinal Chemicals & Botanical Products.
For what period is this 10-Q filing?
This 10-Q filing is for the period of report ending March 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 7, 2024.
Where is USANA Health Sciences Inc. headquartered?
The company's business address is located at 3838 West Parkway Blvd., Salt Lake City, UT 84120-6336.
What is the SEC file number for USANA Health Sciences Inc.?
The SEC file number for USANA Health Sciences Inc. is 001-35024.
From the Filing
0000896264-24-000165.txt : 20240507 0000896264-24-000165.hdr.sgml : 20240507 20240507154946 ACCESSION NUMBER: 0000896264-24-000165 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 59 CONFORMED PERIOD OF REPORT: 20240330 FILED AS OF DATE: 20240507 DATE AS OF CHANGE: 20240507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 24921578 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 10-Q 1 usna-20240330.htm 10-Q usna-20240330 0000896264 12/28 2024 Q1 false 0000896264 2023-12-31 2024-03-30 0000896264 2024-05-03 xbrli:shares 0000896264 2024-03-30 iso4217:USD 0000896264 2023-12-30 iso4217:USD xbrli:shares 0000896264 2023-01-01 2023-04-01 0000896264 us-gaap:CommonStockMember 2022-12-31 0000896264 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000896264 us-gaap:RetainedEarningsMember 2022-12-31 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000896264 2022-12-31 0000896264 us-gaap:RetainedEarningsMember 2023-01-01 2023-04-01 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-04-01 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-04-01 0000896264 us-gaap:CommonStockMember 2023-01-01 2023-04-01 0000896264 us-gaap:CommonStockMember 2023-04-01 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 0000896264 us-gaap:RetainedEarningsMember 2023-04-01 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 0000896264 2023-04-01 0000896264 us-gaap:CommonStockMember 2023-12-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-12-30 0000896264 us-gaap:RetainedEarningsMember 2023-12-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-30 0000896264 us-gaap:RetainedEarningsMember 2023-12-31 2024-03-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 2024-03-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 2024-03-30 0000896264 us-gaap:CommonStockMember 2023-12-31 2024-03-30 0000896264 us-gaap:CommonStockMember 2024-03-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2024-03-30 0000896264 us-gaap:RetainedEarningsMember 2024-03-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-30 usna:region 0000896264 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2024-03-30 0000896264 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2024-03-30 0000896264 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2024-03-30 0000896264 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member 2024-03-30 0000896264 us-gaap:FairValueMeasurementsRecurringMember 2024-03-30 0000896264 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-30 0000896264 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-30 0000896264 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2024-03-30 0000896264 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2023-12-30 0000896264 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2023-12-30 0000896264 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMem